Skip to main content
. 2015 Jun 22;10(6):e0129500. doi: 10.1371/journal.pone.0129500

Table 1. Characteristics of BBD cases/controls and risk/protective factors.

FA FAC FCC
NegativeNum. (%) PositiveNum. (%) P-value Negative Num. (%) Positive Num. (%) P-value Negative Num. (%) Positive Num.(%) P-value
Total 1 1262(100) 308(100) 1427(100) 143(100) 695(100) 875(100)
Age <41 261(21) 171(56) < .0001 409(29) 23(16) 0.002 264(38) 168(19) < .0001
[41,60] 621(49) 107(35) 645(45) 83(58) 265(38) 463(53)
>60 380(30) 30(10) 373(26) 37(26) 166(24) 244(28)
Race AA 319(25) 102(33) 0.002 380(27) 41(29) 0.101 239(34) 182(21) < .0001
CA 818(65) 163(53) 901(63) 80(56) 385(55) 596(68)
Asian 48(4) 16(5) 58(4) 6(4) 26(4) 38(4)
Other 77(6) 27(9) 88(6) 16(11) 45(6) 59(7)
Current OC use No 1189(94) 262(85) < .0001 1311(92) 140(98) 0.007 613(88) 838(96) < .0001
Yes 73(6) 46(15) 116(8) 3(2) 82(12) 37(4)
Number of live birth 0 234(19) 120(39) < .0001 330(23) 24(17) 0.013 177(25) 177(20) 0.011
1–2 645(51) 146(47) 725(51) 66(46) 351(51) 440(50)
≥3 383(30) 42(14) 372(26) 53(37) 167(24) 258(29)
BMI <25 576(46) 180(58) < .0001 691(48) 65(45) 0.498 307(44) 449(51) 0.005
≥25 686(54) 128(42) 736(52) 78(55) 388(56) 426(49)
HRT Never 814(65) 267(87) < .0001 989(69) 92(64) 0.174 514(74) 567(65) < .0001
Estrogen 181(14) 16(5) 176(12) 21(15) 84(12) 113(13)
Combo 230(18) 21(7) 222(16) 29(20) 79(11) 172(20)
Other 2 37(3) 4(1) 40(3) 1(1) 18(3) 23(3)

Note

1 cases with missing values in all 6 factors were not included

2 “HRT, Other” was not used for FAC model selection due to low count.

⌂ indicates P-values from Fisher exact test; all other P-values were from Chi-square test. Abbreviations: FA = Fibroadenoma; FAC = Fibroadenomatoid Change; FCC = Fibrocystic Changes; Num. = Number; Race, AA = African American, CA = Caucasian American; Current OC use = Current oral contraceptive use; BMI = Body Mass Index; HRT = Hormonal replacement therapy; Combo = Estrogen & Progesterone.